Value through Innovation30 August 2015

Boehringer Ingelheim Press Releases

See the latest Boehringer Ingelheim news releases. To quickly find all news releases on a specific topic, please use the fulltext search.

Press Release Archive

back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
29.08.2015

ESC launches new concept for driving innovation in cardiovascular research with exclusive support from Boehringer Ingelheim

28.08.2015

Expansion of the Boehringer Ingelheim Board of Managing Directors / Andreas Neumann responsible for Human Resources

25.08.2015

FDA and EMA accept regulatory applications for Boehringer Ingelheim’s Giotrif® / Gilotrif® (afatinib) for treatment of advanced squamous cell carcinoma of the lung

20.08.2015

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

19.08.2015

CHMP recommends label update for Giotrif® with addition of data demonstrating overall survival benefit for patients with EGFR mutation-positive lung cancer

17.08.2015

New data show Spiolto® Respimat® provides meaningful quality of life improvements in COPD

12.08.2015

Boehringer Ingelheim and Circuit Therapeutics announce new collaboration to discover novel medicines for obesity

04.08.2015

Boehringer Ingelheim experiences slight growth in local currency terms in the first half of 2015

28.07.2015

Boehringer Ingelheim enters into an exclusive license agreement with Hanmi Pharmaceutical to develop 3rd generation EGFR targeted therapy in lung cancer

24.07.2015

MHRA review confirms benefit/risk profile of Alteplase - the only licensed clot buster for acute ischaemic stroke

15.07.2015

Boehringer Ingelheim Welcomes the Inclusion of OFEV® (nintedanib*) in the Updated International Treatment Guidelines for Idiopathic Pulmonary Fibrosis (IPF)

06.07.2015

Phase III data published in The Lancet Oncology shows a significant overall survival benefit of Giotrif® (afatinib) compared to Tarceva® (erlotinib) in patients with previously treated advanced squamous cell carcinoma of the lung

02.07.2015

New advance in COPD maintenance treatment, Spiolto® Respimat®, approved in first European countries

-  
01.07.2015

Boehringer Ingelheim Animal Health: 2015 European PRRS Research Award open for submissions until July 31st

22.06.2015

Idarucizumab* reverses the anticoagulant effect of dabigatran within minutes in patient study

16.06.2015

New publication in The Lancet describes effective reversal of Pradaxa® in healthy volunteers

08.06.2015

Type 2 diabetes: Patients reporting better quality of communication by their physician show improved self-care

08.06.2015

Empagliflozin/metformin demonstrates reductions in blood glucose in data presented at ADA

back 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16